Barry Cohen

Barry Cohen

Barry Cohen has nearly 30 years in communications and marketing, the majority in senior positions at three large international health care companies – Abbott Laboratories, Warner-Lambert (now part of Pfizer) and Bayer, Inc.

At Abbott, Cohen was a member of the company’s investor relations team, responsible for preparing all financial analyst presentations. He also oversaw the company’s award-winning annual and quarterly reports and was responsible for both the company’s investor seminar and annual shareholders’ meeting.

After relocating to Arizona, Cohen served as editor of M.D. News, a magazine for Phoenix-area physicians. Later he was a reporter for a weekly newspaper in a north Phoenix, where he specialized in business articles and profiles of local publicly traded companies.

To further his knowledge and understanding of financial markets, Cohen earned a series 7 broker’s license and was employed at Charles Schwab as a registered representative.  He returned to the communications field with CPRi Communications, where he wrote numerous case studies and bylined articles for the company’s clients in the health care information technology industry. Later, he worked for a Scottsdale, Ariz.-based investment bank preparing profiles of companies being offered for sale.

Recent Articles

Buyout May Be Lilly’s Best Hope

A shareholder proposal may clear the way for a takeover of the pharmaceutical giant.

How to Play the Personalized Medicine Boom

Molecular diagnostics stocks may have some untapped upside.

How Microsoft Can Profit Big from an Electronic Medical Records Revolution

Microsoft NASDAQ:MSFT could be getting into electronic health and medical records big-time with its HealthVault system, threatening General Electric NYSE:GE McKesson NYSE:MCK and others.

Investors Can Clean Up with Medical Waste Giant Stericycle (SRCL)

Stericycle NASDAQ:SRCLE, a medical waste disposal stock, is an industry giant dwarfing all except for competitor Sharps Compliance NASDAQ:SMED.

Can Merck Shares Escape the Muck?

A state court trial vicotry may be the light at the end of the tunnel.